American Hospital Association January 10, 2025

Prices for the top 25 brand-name Medicare Part D drugs have increased by an average of 98% since entering the market, according to a report released Jan. 9 by the AARP Public Policy Institute. That price growth has often exceeded...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Insurance, Medicare, Pharma, Pharma / Biotech, Survey / Study, Trends
Podcast: The Scope of Medicare Fraud
Pharmacy benefit managers steer Medicare patients to use their own pharmacies
Medicare and telehealth: more restrictive rules could hit patients in 2025
A Stronger Medicare Program—Now And Into The Future
Medicare can now cover Eli Lilly's Zepbound for sleep apnea, Health Department agency says

Share This Article